The 42 rating InvestorsObserver gives to Bellicum Pharmaceuticals Inc (BLCM) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 37 percent of stocks in the Biotechnology industry, BLCM’s 42 overall rating means the stock scores better than 42 percent of all stocks.
BLCM has an Overall Score of 42. Find out what this means to you and get the rest of the rankings on BLCM!